Acceso a la atención médica Press Releases
CHARLESTON, W. Va. – As lawmakers were finishing up the legislative session this past spring, they continued to think about 12,380 West Virginians who will hear the words “you have cancer” this year.
The U.S. House of Representatives is expected to pass legislation today aimed at improving access to clinical trials for communities of color and decreasing health disparities.
More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. District Court for the Southern District of New York to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care
he U.S. House of Representatives passed the Removing Barriers to Colorectal Cancer Screening Act unanimously today.
Washington, D.C. —The Trump administration issued a interim final rule Friday that would significantly change how Medicare pays for certain prescription drugs.
As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.
Cancer patients and survivors continue to experience potentially serious health care delays during the pandemic, and tomorrow leadership across Oklahoma will shine a light on the disparities affecting Native Americans’ cancer outcomes.
Twenty patient groups representing millions of Americans with pre-existing conditions are urging the U.S. Supreme Court to prioritize patient protections, including those for people with pre-existing conditions, when it hears oral arguments Tuesday in the case of California v. Texas (previously Texas v. United States).
The American Cancer Society Cancer Action Network (ACS CAN) today released a report detailing the costs of treating cancer, specifically out-of-pocket costs typical cancer patients face. The report found U.S. cancer patients in 2018 spent $5.6 billion in out-of-pocket costs for cancer treatment
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN por sus siglas en inglés) publicó hoy un informe que detalla los costos del tratamiento de cáncer, específicamente los gastos de bolsillo que enfrentan los típicos pacientes de cáncer.